SCHEMBL31407482

SCHEMBL31407482

CN(C(=O)OCC1c2ccccc2-c2ccccc21)[C@@H](Cc1ccc(N)nc1)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CPB2 Q96IY4 8/20 0.42
CPB1 P15086 3/20 0.39
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
FABP5 Q01469 3/20 0.38
FABP7 O15540 2/20 0.38
CPA1 P15085 1/20 0.37
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
KMT2A Q03164 1/20 0.36
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB1 P18505 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36
GABRB2 P47870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29633871 0.89 ITGB3 (0.40) ITGB3ITGA2BFABP5FABP7PPARG
SCHEMBL25172913 0.89 ITGB3 (0.40) ITGB3ITGA2BFABP5FABP7PPARG
SCHEMBL30802522 0.89 ITGB3 (0.40) ITGB3ITGA2BFABP5FABP7PPARG
SCHEMBL25179614 0.89 ITGB3 (0.40) ITGB3ITGA2BFABP5FABP7PPARG
SCHEMBL27041668 0.88 ITGB3 (0.39) ITGB3ITGA2BFABP5FABP7PPARG
SCHEMBL21838070 0.88 ITGB3 (0.39) ITGB3ITGA2BFABP5FABP7PPARG
SCHEMBL27041664 0.88 ITGB3 (0.39) ITGB3ITGA2BFABP5FABP7PPARG
SCHEMBL21838067 0.88 ITGB3 (0.39) ITGB3ITGA2BFABP5FABP7PPARG
SCHEMBL30759375 0.88 ITGB3 (0.39) ITGB3ITGA2BFABP5FABP7PPARG
SCHEMBL25183125 0.87 FABP5 (0.41) ITGB3ITGA2BFABP5FABP7PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015313-A1 AMINO ACID ACTIVE ESTER AND SALT THEREOF PEPTIDREAM INC (JP) 2026-01-15 US disclosed
EP-4534524-A1 AMINO ACID ACTIVE ESTER AND SALT THEREOF PeptiDream Inc. (JP) 2025-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015313-A1 AMINO ACID ACTIVE ESTER AND SALT THEREOF NSUN3, BCAT1, SLC43A1 CPB2 2297/4885CPB1 1230/4885ITGB3 2864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.